patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: up-up-n-away

''Aberman has said Pluristem is in talks with large pharmaceutical companies in the United States, Europe and Japan to market the treatment though he would not disclose names.

"We have a lot of interest," he said. (Editing by Mike Nesbit) ''

http://www.reuters.com/article/idUSLDE70H14820110118?feedType=RSS&feedName=rbssHealthcareNews&rpc=43

weee

Share
New Message
Please login to post a reply